Literature DB >> 15469051

Opioid tolerance and neuroplasticity.

Jianren Mao1.   

Abstract

Opioid analgesics are highly effective for treating many forms of acute and chronic pain. The development of opioid analgesic tolerance is a pharmacological phenomenon indicative of the cellular and system adaptation that could affect the clinical use of opioid analgesics. Activation of N-methyl-D-aspartate receptors and protein kinase C as well as regulation of glutamate transporters has been implicated in the mechanisms of opioid tolerance, suggesting a possible link between neural plasticity and the mechanisms of opioid tolerance. More recent studies have shown that neural plasticity associated with the development of opioid tolerance may activate a pronociceptive mechanism within the central nervous system that could counteract the analgesic effects of opioids. Thus, exposure to opioids could lead to two seemingly unrelated cellular processes, i.e. (1) the development of opioid tolerance--a negative sign of cellular adaptation, and (2) the development of opioid-induced pain sensitivity--a positive sign of cellular adaptation. The converging effects of these cellular mechanisms would significantly reduce the opioid analgesic efficacy. The current evidence also suggests new approaches for improving the clinical use of opioid analgesics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15469051

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  3 in total

Review 1.  Addressing the intersecting problems of opioid misuse and chronic pain treatment.

Authors:  Richard A Denisco; Redonna K Chandler; Wilson M Compton
Journal:  Exp Clin Psychopharmacol       Date:  2008-10       Impact factor: 3.157

2.  Inflammasome in drug abuse.

Authors:  Enquan Xu; Jianuo Liu; Xiaobei Wang; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-12-25

Review 3.  The Effects of Low-Dose Ketamine on Acute Pain in an Emergency Setting: A Systematic Review and Meta-Analysis.

Authors:  Eun Nam Lee; Jae Hoon Lee
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.